跳至主要内容
临床试验/ISRCTN68505294
ISRCTN68505294已完成不适用

Effects of moderate red wine consumption on antioxidant and redox-sensitive immunological parameters in healthy volunteers

Institute for Molecular Biotechnology (Germany)0 个研究点目标入组 105 人开始时间: 2005年5月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Healthy, normal-weight male and female subjects between 18 and 50 years of age.

排除标准

  • 1. Pregnancy and lactation: women not taking oral contraceptives underwent a pregnancy test to exclude an unknown pregnancy before starting the intervention
  • 2. Known diseases of the liver and pancreas or dysfunctions of the gastro-intestinal tract associated with maldigestion or malabsorption
  • 3. Hypertension
  • 4. Dysfunctions of the lipid metabolism
  • 5. Hyperuricaemia/gout
  • 6. Kidney dysfunctions
  • 7. Autoimmune diseases
  • 8. Diabetes mellitus type I or type II
  • 9. Acute infectious diseases
  • 10. Eating disorders
  • 11. Allergy to hen's eggs (albumen used as finings in red wine)
  • 12. Alcohol abuse (more than 40 g/day) or previous addiction to alcohol
  • 13. Drug abuse
  • 14. Tobacco smoking during the last 6 months prior to the study
  • 15. Regular intake of pharmaceuticals, which influence the immune system and/or the antioxidant capacity in plasma (anti-inflammatory drugs including cortisol containing medications, immune stimulants) as well as intake of drugs which might cause adverse affects by interacts with alcohol
  • 16. Intake of nutritional supplements e.g. multivitamins, supplements containing vitamin A, C and/or vitamin E, fish oil or red wine preparations, bioactive concentrates
  • 17. Excessive exercising (competitive athletes) defined as greater than 10 hours strenous exercise per week
  • 18. Limited contractual capability
  • 19. Every other state opposed to participation in the study stated by the medical supervisor
  • 20. Participation in any other clinical trial (ongoing or completed less than 30 days prior to the present study)

研究者

发起方
Institute for Molecular Biotechnology (Germany)

相似试验